Monitoring
TLS is most commonly associated with the initiation of chemotherapy, particularly regimens with highly active, cell cycle phase-specific drugs (e.g., etoposide, cytarabine).[1][2][12][20] Recurrence is rare. No additional follow-up visits, tests, or imaging are usually required after successful treatment, but patients will continue to attend for chemotherapy and oncologic follow-up of their underlying malignancy.
Use of this content is subject to our disclaimer